Return to work will be 'therapeutic' for King Charles and getting back to 'normality' could speed up his cancer recovery, top expert Professor Karol Sikora claims
Buckingham Palace today announced the King would be returning to public-facing duties after a three-month absence. (Source: the Mail online | Health)
Source: the Mail online | Health - April 26, 2024 Category: Consumer Health News Source Type: news
King Charles' health history revealed, from his cancer battle and broken rib to his 'sausage fingers'
Buckingham Palace today revealed King Charles will return to public-facing duties. Here, MailOnline details Charles' known health issues over the years. (Source: the Mail online | Health)
Source: the Mail online | Health - April 26, 2024 Category: Consumer Health News Source Type: news
How is the King's cancer treatment going?
The King's medical team are "sufficiently pleased" with his progress after he was diagnosed with cancer in February. (Source: BBC News | Health | UK Edition)
Source: BBC News | Health | UK Edition - April 26, 2024 Category: Consumer Health News Source Type: news
Africa: Africa Steps Up the Fight as Non-Communicable Diseases Rise Sharply
[allAfrica] Non-communicable diseases, or NCDs, are a leading cause of death globally, with a disproportionate impact on low- and middle-income countries. NCDs are long-term conditions that are not transmitted from person to person. They can develop slowly over time or cause sudden death. According to WHO, the five main types are cardiovascular diseases (heart attacks and strokes), cancers, chronic respiratory diseases (like asthma), diabetes, and mental health conditions. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - April 26, 2024 Category: African Health Tags: Africa Health and Medicine Noncommunicable Diseases Source Type: news
Quadruplet Shows 'Excellent Activity' in Myeloma Patients Who Defer HSCT
(MedPage Today) -- Adding the CD38 monoclonal antibody isatuximab (Sarclisa) to a backbone of carfilzomib (Kyprolis), lenalidomide (Revlimid), and dexamethasone (KRd) induced deep and durable responses in a multiple myeloma study of untreated transplant... (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - April 26, 2024 Category: Hematology Source Type: news
